
New line of attack on a dreaded disease
In honor of a friend fighting a brain tumor, Turkish financier’s multimillion-dollar gift funds genomic analysis of deadly glioblastomas
Few diseases are as feared, or as deadly, as glioblastoma multiforme (GBM), the most aggressive and most common form of brain cancer, which accounts for about 60 percent of all brain tumors diagnosed in the United States each year. Over the past five years, improvements in radiotherapy and surgical techniques, and the advent of drugs that block blood vessel formation in tumors have significantly increased survival time in patients with GBM. But despite these advances, on average these patients...
Kavli neuroscience institute to cast an even wider scientific net

Building upon a grant made in 2003 that established the Kavli Institute for Neuroscience at Yale, The Kavli Foundation...
In life and work, alumnus touched countless hearts
There could be no greater gratification for a physician–scientist than seeing the fruits of his or her own research...

A big birthday for Child Study Center
A century of child development research and compassionate care for childhood disorders is marked by world-renowned Yale department
In 11 steps, chemists make a giant leap
In the latest chapter of a 15-year scientific story spanning the globe from the South Pacific to New Haven, a team of...
Surgeons-turned-detectives explore the dawn of chemotherapy
Thanks to the unearthing of long-lost medical records by two dogged surgeons, the full story of the first use of...
New grant from VA supports a fresh look at primary care training
The United States faces a severe shortage of physicians in the coming decades. As the health care needs of the aging...

Deputy dean is stalwart in a whirlwind of change in biomedical research















